135 related articles for article (PubMed ID: 30514404)
1. Does metformin usage improve survival in head and neck squamous cell carcinoma? A population-based study.
Quimby AE; Lebo NL; Griffiths R; Hall S; Dimitroulakos J; Johnson-Obaseki S
J Otolaryngol Head Neck Surg; 2018 Dec; 47(1):74. PubMed ID: 30514404
[TBL] [Abstract][Full Text] [Related]
2. Survival impact and toxicity of metformin in head and neck cancer: An analysis of the SEER-Medicare dataset.
Stokes WA; Eguchi M; Amini A; Hararah MK; Ding D; McDermott JD; Bradley CJ; Karam SD
Oral Oncol; 2018 Sep; 84():12-19. PubMed ID: 30115470
[TBL] [Abstract][Full Text] [Related]
3. Impact of metformin on disease control and survival in patients with head and neck cancer: a retrospective cohort study.
Lee DJ; McMullen CP; Foreman A; Huang SH; Lu L; Xu W; de Almeida JR; Liu G; Bratman SV; Goldstein DP
J Otolaryngol Head Neck Surg; 2019 Jul; 48(1):34. PubMed ID: 31345259
[TBL] [Abstract][Full Text] [Related]
4. Effect of statin use on oncologic outcomes in head and neck squamous cell carcinoma.
Lebo NL; Griffiths R; Hall S; Dimitroulakos J; Johnson-Obaseki S
Head Neck; 2018 Aug; 40(8):1697-1706. PubMed ID: 29934959
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.
Guo YZ; Sun HH; Wang XT; Wang MT
J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634
[TBL] [Abstract][Full Text] [Related]
6. Can metformin improve 'the tomorrow' of patients treated for oesophageal cancer?
Van De Voorde L; Janssen L; Larue R; Houben R; Buijsen J; Sosef M; Vanneste B; Schraepen MC; Berbée M; Lambin P
Eur J Surg Oncol; 2015 Oct; 41(10):1333-9. PubMed ID: 26091848
[TBL] [Abstract][Full Text] [Related]
7. Association between metformin use and improved survival in patients with laryngeal squamous cell carcinoma.
Sandulache VC; Hamblin JS; Skinner HD; Kubik MW; Myers JN; Zevallos JP
Head Neck; 2014 Jul; 36(7):1039-43. PubMed ID: 23784886
[TBL] [Abstract][Full Text] [Related]
8. Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population.
Kemnade JO; Florez M; Sabichi A; Zhang J; Jhaveri P; Chen G; Chen A; Miller-Chism C; Shaun B; Hilsenbeck SG; Hernandez DJ; Skinner HD; Sandulache VC
Oral Oncol; 2023 Oct; 145():106536. PubMed ID: 37562095
[TBL] [Abstract][Full Text] [Related]
9. Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer.
Arrieta O; Varela-Santoyo E; Soto-Perez-de-Celis E; Sánchez-Reyes R; De la Torre-Vallejo M; Muñiz-Hernández S; Cardona AF
BMC Cancer; 2016 Aug; 16():633. PubMed ID: 27519177
[TBL] [Abstract][Full Text] [Related]
10. Effect of metformin on the incidence of head and neck cancer in diabetics.
Yen YC; Lin C; Lin SW; Lin YS; Weng SF
Head Neck; 2015 Sep; 37(9):1268-73. PubMed ID: 24801563
[TBL] [Abstract][Full Text] [Related]
11. Treatment results and prognostic factors for advanced squamous cell carcinoma of the hypopharynx treated with concurrent chemoradiotherapy.
Taguchi T; Nishimura G; Takahashi M; Komatsu M; Sano D; Sakuma N; Yabuki K; Arai Y; Takahashi H; Hata M; Koike I; Oridate N
Cancer Chemother Pharmacol; 2014 Jun; 73(6):1147-54. PubMed ID: 24658628
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and long-term outcomes of head and neck squamous cell carcinoma after solid organ transplantation.
Alsidawi S; Price KA; Chintakuntlawar AV; Westin GF; Garcia JJ; Ma DJ; Okuno SH
Oral Oncol; 2017 Sep; 72():104-109. PubMed ID: 28797445
[TBL] [Abstract][Full Text] [Related]
13. Metformin Prevents the Progression of Dysplastic Mucosa of the Head and Neck to Carcinoma in Nondiabetic Patients.
Lerner MZ; Mor N; Paek H; Blitzer A; Strome M
Ann Otol Rhinol Laryngol; 2017 Apr; 126(4):340-343. PubMed ID: 28103701
[TBL] [Abstract][Full Text] [Related]
14. Effects of Statin, Aspirin or Metformin Use on Recurrence-Free and Overall Survival in Patients with Biliary Tract Cancer.
McNamara MG; Aneja P; Le LW; Horgan AM; McKeever E; Knox JJ
Hepatogastroenterology; 2015 May; 62(139):564-9. PubMed ID: 26897929
[TBL] [Abstract][Full Text] [Related]
15. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
[TBL] [Abstract][Full Text] [Related]
16. Effect of metformin on progression of head and neck cancers, occurrence of second primary cancers, and cause-specific survival.
Kwon M; Roh JL; Song J; Lee SW; Kim SB; Choi SH; Nam SY
Oncologist; 2015 May; 20(5):546-53. PubMed ID: 25802404
[TBL] [Abstract][Full Text] [Related]
17. The roles of PTEN, cMET, and p16 in resistance to cetuximab in head and neck squamous cell carcinoma.
da Costa AABA; Costa FD; Araújo DV; Camandaroba MPG; de Jesus VHF; Oliveira A; Alves ACF; Stecca C; Machado L; de Oliveira ACF; de Oliveira TB; Nicolau UR; de Lima VCC
Med Oncol; 2018 Nov; 36(1):8. PubMed ID: 30478503
[TBL] [Abstract][Full Text] [Related]
18. Metformin exposure and survival in head and neck cancer: A large population-based cohort study.
Alcusky M; Keith SW; Karagiannis T; Rabinowitz C; Louis DZ; Maio V
J Clin Pharm Ther; 2019 Aug; 44(4):588-594. PubMed ID: 31293011
[TBL] [Abstract][Full Text] [Related]
19. Surgery with postoperative radiotherapy for pN2 head and neck squamous cell carcinoma.
Joo YH; Cho KJ; Park JO; Nam IC; Kim CS; Cho HJ; Kim MS
Acta Otolaryngol; 2013 Oct; 133(10):1104-9. PubMed ID: 24032573
[TBL] [Abstract][Full Text] [Related]
20. Impact of age on the overall survival benefits of anti-EGFR-containing regimens in head and neck squamous cell carcinoma: A meta-analysis of randomized controlled trials.
Zhao Y; Liu W; Sun M; Miao Q; Liu Y; Tian H; Su Y; Han F
Crit Rev Oncol Hematol; 2019 Mar; 135():39-46. PubMed ID: 30819445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
